Body Fat Reduction Market to Witness Robust Growth by 2028

March 14, 2023/Industry News Global/ -- This new report from Stratview Research analyses the Body Fat Reduction Market over the forecast period from 2022 to 2028. The insights of the report shall enable informed decision-making and strategy formulation for the near future to capitalize on the opportunities.

Body Fat Reduction Market Overview:

The body fat reduction market was estimated at US$ 8.8 million in 2021 and is expected to grow at a CAGR of 10.1% during 2022-2028 to reach US$ 17.31 million in 2028.

Drivers

The following are the major players in the body fat reduction market:

• Amirlak Plastic Surgery
• JK plastic surgery center
• Apollo cosmetic clinics
• Elite Body Sculpture
• The Plastic Surgery Clinics
• Transform Cosmetic Surgery
• VIDA Wellness & Beauty
• Elite Body Sculpture
• Waldman Schantz Plastic Surgery Centerm
• VLCC Wellness & Beauty Center

Segment Analysis

The market is divided based on procedure type, and end user. On the basis of procedure type, the market is further segmented into surgical and non-surgical. The surgical segment is further divided into liposuction, abdominoplasty. The non surgical segment is divided into cryolipolysis, ultrasound, laser lipolysis.

On the basis of end user, the market is segmented into hospitals, aesthetic clinics, and others. In 2021, the hospital segment led the body fat reduction market. According to the American Society of Plastic Surgeons, around 18 million people in the United States underwent minimally invasive aesthetic procedures in 2018, with the number gradually increasing since then. Because medical facilities in many established and developing countries are robust, they are well equipped with cutting-edge technology and high-end technologies. A considerable number of trained aesthetic practitioners are linked with hospitals since they provide all of the necessary facilities to carry out such treatments. Furthermore, consumer choice comes into play, as people feel more secure having treatments from a well-known hospital because they have insurance coverage for such treatments. Several specialty hospitals have collaborations with reputable organisations.

Aesthetic clinics, on the other hand, are expected to expand rapidly during the forecast period. Aesthetic clinics are becoming more popular as a result of their higher service quality, personalised focus to clients, as well as lower treatment costs compared to other venues. Aesthetic clinics also provide comprehensive treatment for skin, hair, body, and facial disorders, as well as basic spa and beauty treatments like waxing and manicures, dentistry, and removal of skin tags, warts, freckles, birthmarks, among others. This is the key indirect source of market growth.

The body fat reduction market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to be the largest body fat reduction market region in 2021. North America dominated the body fat reduction market and accounted for the largest revenue share in 2021, owing to technological developments and an increase in the number of people choosing for procedures in the industry. The region has a high level of aesthetic awareness, and the number of people opting for cosmetic procedures has increased as well. According to estimates from the International Society of Aesthetic Plastic Surgery, the region has the largest pool of cosmetic professionals in the country, and it has one of the highest treatment volumes for body fat reduction treatments. During the forecast period, body fat reduction is expected to grow at the quickest rate in Asia Pacific. This is mainly attributable to the region's increasing urbanisation. Because this location has such a vast population, many individuals are interested in cosmetic enhancement. Furthermore, the region has a strong social media presence, which, along with low treatment prices and high-quality procedure service, is driving market growth. In 2019, approximately 11,184 surgical body fat reduction procedures were performed in India.

Get access to a deeper coverage of the impact of COVID-19 on this Market here: 

https://www.stratviewresearch.com/Request-Sample/3113/body-fat-reduction-market.html#form

About Stratview Research

Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

For enquiries,
Contact:
Stratview Research
E-mail: [e-mail]
Direct: [phone]

 

Brain Health Supplements Market to experience growth by 2028

March 09, 2023/Industry News Global/ -- This new report from Stratview Research analyses the Brain Health Supplements Market over the forecast period from 2022 to 2028. The insights of the report shall enable informed decision-making and strategy formulation for the near future to capitalize on the opportunities.

Brain Health Supplements Market Overview:

The brain health supplements market was estimated at US$ 8.23 billion in 2021 and is expected to grow at a CAGR of 8% during 2022-2028 to reach US$ ~17.40 billion in 2028.

Drivers

The following are the major players in the brain health supplements market:

• AlternaScript
• HVMN Inc.
• Intelligent Labs
• Natural Factors Nutritional Products Ltd.
• NOW Foods
• Onnit Labs, Inc.
• Peak Nootropics
• Purelife Bioscience Co., Ltd.
• Reckitt Benckiser Group plc.
• Teva Pharmaceutical Industries Ltd.

Manufacturers have been concentrating on creating a range of supplements that are specifically aimed at athletes who place an emphasis on improving their performance and preserving their composure. Over the following few years, this is anticipated to increase demand for supplements supporting brain health.

Segment Analysis

The market is segmented based on supplement type, product, age group, application, distribution channel, and geography. On the basis of supplement type, the segment is divided into tablets, capsules, others.

On the basis of product, the segment is divided into natural molecules, herbal extract, vitamins and minerals. In terms of global revenue for 2021, the natural molecule sector held the biggest market share and is predicted to continue to dominate. This market's expansion is anticipated to be aided by the growing preference for brain supplements manufactured from natural ingredients over synthetic ones. Companies are also emphasising the use of natural ingredients in their products.

Based on age group, the market is segmented into children, adults, elderly.

On the basis of application, the market is segmented into memory enhancement, attention and focus, depression and mood, sleep and recovery, anti-aging and longevity, stress & anxiety. In terms of global revenue in 2021, the memory improvement sector held the biggest market share and is predicted to continue to dominate. The millennial generation is engaging in a variety of activities outside of their primary occupation, such as adventure sports, social events, and part-time work, which needs them to be intellectually awake throughout the day. Therefore, it is anticipated that changing consumer habits will increase demand for these goods. A survey from the Organization for Economic Cooperation and Development indicates that part-time employment is becoming more prevalent in nations like Germany, Italy, France, and Austria. Over the projection period, the shift in consumer lifestyle is anticipated to increase demand for memory-boosting supplements.

Based on distribution channel, the market is divided into supermarkets & hypermarkets, drug stores, online stores, and others.

The brain health supplements market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2021, North America contributed most to the market. The demand for the product in North America is being driven by consumers' increased concerns about their mental health. Nearly 75% of U.S. adults consume dietary supplements that contain vitamins, minerals, and herbal ingredients to enhance brain health, energy, and performance, according to statistics released by the U.S. National Library of Medicine in April 2020. These trends are probably going to accelerate the market expansion in the nation. In America, loneliness and uncertainty about the future are major stressors for adolescents and young adults, according to data published by the American Psychological Association in October 2020, which is expected to lead an increase in the number of adults to use brain health supplements for the right kind of treatment.

Get access to a deeper coverage of the impact of COVID-19 on this Market here: https://www.stratviewresearch.com/Request-Sample/3114/brain-health-supplements-market.html#form

About Stratview Research

Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

For enquiries,
Contact:
Stratview Research
E-mail: [e-mail]
Direct: [phone]

 

Cancer Supportive Care Drugs Market: Revenue and growth prediction till 2026 with covid-19 impact analysis

March 07, 2023/Industry News Global/ -- This new report from Stratview Research analyses the Cancer Supportive Care Drugs Market over the forecast period from 2022 to 2028. The insights of the report shall enable informed decision-making and strategy formulation for the near future to capitalize on the opportunities.

Cancer Supportive Care Drugs Market Overview:

The cancer supportive care drugs market was estimated at US$ 20.9 billion in 2021 and is expected to grow at a CAGR of 2.04% during 2022-2028 to reach US$ ~21.40 billion in 2028.

Drivers

The following are the major players in the cancer supportive care drugs market:

• Amgen, Inc.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc (GSK)
• Helsinn Healthcare SA
• Heron Therapeutics, Inc.
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Novartis AG

Rising technological and therapeutic developments as well as an increase in product launches by market participants are factors driving the growth of the global market for asthma and COPD medications. For the introduction of new products, certain governmental organisations work with industry participants.

Segment Analysis

Based on drug class, application, distribution channel, and geography, the market has been divided into segments. On the basis of drug class, the market has been segmented into G-CSFs (Granulocyte-colony Stimulating Factors), ESAs (Erythropoiesis Stimulating Agents), anti-emetics, bisphosphonates, opioids, NSAIDs, and others. The Granulocyte Colony Stimulating Factor (G-CSF) category had the highest revenue. It is the main option for treating neutropenia brought on by cancer. It is one of the most frequently prescribed supportive care medications for lymphoma and breast malignancies. For instance, in the UK, G-CSF is given to 84% of patients with lymphoma and 70% of breast cancer patients, respectively. However, the declining usage of myelosuppressive chemotherapy, which limits the formation of G-CSF, is a consequence of the increased use of immuno-oncology (IO) drugs in therapy, such as anti-PD-1/L1s. During the anticipated term, positive growth in the antiemetics segment is anticipated.

Chemotherapy-induced nausea and vomiting (CINV) is one of the most frequent issues that patients with chemotherapy deal with. The introduction of more recent medications including Cinvanti, Sustol, and Varubi is to blame for the rise. However, the overall CINV medicines sales would be impacted by the patent expiry of important antiemetic medications like Emend. During the projection period, the growth of the opioid segment is anticipated to slow. Opioid medicines are subject to strict controls imposed by governments in many nations, including the US government. As a result, the rate of opioid medicine prescriptions has dramatically decreased.

Based on application, the cancer supportive care drugs market has been divided into breast cancer, lung cancer, colorectal cancer, prostate cancer, liver cancer, stomach cancer, and others.

On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies.

The cancer supportive care drugs market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The launch and quick adoption of biosimilars as well as curbs on the prescription of opioids are likely to cause the market in North America and other developed regions to contract over the course of the forecast period. Additionally, tailored, targeted medicines are widely used in these regions due to their lower incidence of adverse effects, increasing public knowledge of their availability, and supportive reimbursement practises for expensive targeted therapies. High unmet needs for cancer supportive care exist in developing nations such those in the Middle East and Africa, Latin America, and Asia-Pacific. Chemotherapy is still a common treatment because of the underdeveloped healthcare systems and low levels of disposable income in these areas. These elements are anticipated to fuel market expansion in these regions.

Get access to a deeper coverage of the impact of COVID-19 on this Market here:https://www.stratviewresearch.com/Request-Sample/3140/cancer-supportive-care-drugs-market.html#form

About Stratview Research

Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

For enquiries,
Contact:
Stratview Research
E-mail: [e-mail]
Direct: [phone]